243 related articles for article (PubMed ID: 32976882)
1. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
2. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
[TBL] [Abstract][Full Text] [Related]
3. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
5. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
[TBL] [Abstract][Full Text] [Related]
6. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
[TBL] [Abstract][Full Text] [Related]
8. Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer.
Chen Y; Ma Z; Shen X; Li L; Zhong J; Min LS; Xu L; Li H; Zhang J; Dai L
Biomed Res Int; 2018; 2018():5276240. PubMed ID: 30175133
[TBL] [Abstract][Full Text] [Related]
9. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
11. [LC-MS/MS-based screening of new protein biomarkers for cervical precancerous lesions and cervical cancer].
Qiu F; Chen F; Liu D; Xu J; He J; Xiao J; Cao L; Huang X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):13-22. PubMed ID: 30692061
[TBL] [Abstract][Full Text] [Related]
12. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry.
Wolrab D; Chocholoušková M; Jirásko R; Peterka O; Holčapek M
Anal Bioanal Chem; 2020 Apr; 412(10):2375-2388. PubMed ID: 32078000
[TBL] [Abstract][Full Text] [Related]
13. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer.
Boichenko AP; Govorukhina N; Klip HG; van der Zee AG; Güzel C; Luider TM; Bischoff R
J Proteome Res; 2014 Nov; 13(11):4995-5007. PubMed ID: 25232869
[TBL] [Abstract][Full Text] [Related]
14. Lipidomic analysis of plasma in patients with lacunar infarction using normal-phase/reversed-phase two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry.
Yang L; Lv P; Ai W; Li L; Shen S; Nie H; Shan Y; Bai Y; Huang Y; Liu H
Anal Bioanal Chem; 2017 May; 409(12):3211-3222. PubMed ID: 28251292
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
16. Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure.
Rong J; He T; Zhang J; Bai Z; Shi B
Lipids Health Dis; 2023 May; 22(1):66. PubMed ID: 37210547
[TBL] [Abstract][Full Text] [Related]
17. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Gong LL; Yang S; Zhang W; Han FF; Lv YL; Xuan LL; Liu H; Liu LH
J Pharm Biomed Anal; 2020 Jan; 177():112848. PubMed ID: 31479998
[TBL] [Abstract][Full Text] [Related]
18. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
19. Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry.
Serna J; García-Seisdedos D; Alcázar A; Lasunción MÁ; Busto R; Pastor Ó
Chem Phys Lipids; 2015 Jul; 189():7-18. PubMed ID: 26004846
[TBL] [Abstract][Full Text] [Related]
20. Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis.
Wang X; Gu X; Song H; Song Q; Gao X; Lu Y; Chen H
Anal Chim Acta; 2015 Sep; 893():77-83. PubMed ID: 26398425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
